Valuing Health Care Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies
Book contents
- Frontmatter
- Contents
- List of Tables
- List of Figures
- List of Boxes
- Acknowledgments
- 1 Introduction
- 2 Evidence of effectiveness: evaluating its quality
- 3 Utility assessment for estimating quality-adjusted life years
- 4 Measuring costs
- 5 From cost–effectiveness ratios to resource allocation: where to draw the line?
- 6 Valuing health care benefits in money terms
- 7 Discounting health effects for medical decisions
- 8 Statistical issues in cost–effectiveness analyses
- 9 Decision trees and Markov models in cost–effectiveness research
- 10 The use of cost–effectiveness/cost–benefit analysis in actual decision making: current status and prospects
- Notes
- References
- Index
List of Boxes
Published online by Cambridge University Press: 07 December 2009
Edited by
Book contents
- Frontmatter
- Contents
- List of Tables
- List of Figures
- List of Boxes
- Acknowledgments
- 1 Introduction
- 2 Evidence of effectiveness: evaluating its quality
- 3 Utility assessment for estimating quality-adjusted life years
- 4 Measuring costs
- 5 From cost–effectiveness ratios to resource allocation: where to draw the line?
- 6 Valuing health care benefits in money terms
- 7 Discounting health effects for medical decisions
- 8 Statistical issues in cost–effectiveness analyses
- 9 Decision trees and Markov models in cost–effectiveness research
- 10 The use of cost–effectiveness/cost–benefit analysis in actual decision making: current status and prospects
- Notes
- References
- Index
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Valuing Health CareCosts, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies, pp. xPublisher: Cambridge University PressPrint publication year: 1995